Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
MRKMerck & Co.
FinDog View：Neutral
| Metric | IDXX | MRK |
|---|
| Close | 551.21 | 149.52 |
| Market Cap | $43.9B | $371B |
| 1M | +5.56% | +2.90% |
| P/E (TTM) | 38.9 | 117.2 |
| Forward P/E | 32.2 | 19.6 |
| P/E 5-Yr Percentile | 7 | 81 |
| P/S | 9.8 | 5.6 |
| P/B | 27.5 | 8.9 |
| Dividend Yield | — | 2.87% |
| Latest Quarter Revenue | $1.2B | $16.6B |
| Revenue YoY | +9.7% | +5.1% |
| Gross Margin | 64.0% | 73.5% |
| Latest Quarter EPS | 4.27 | -0.54 |
| Avg Post-Earnings Move | ±1.8% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.68% | 3.37% |
| 90-Day Net Insider Buying | −$1.2M | −$30.0M |
IDXX · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
